← Back to Search

Laser Therapy

Fractional CO2 Laser for Hypertrophic Scars

N/A
Waitlist Available
Led By Frankie Fraulin, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children (age 1- 17) who present with hypertrophic scarring following an acute injury or burn, with stable closed scars at least 3 months post wound closure.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 8 months
Awards & highlights

Study Summary

This trial will help to expand the evidence base for the use of ablative fractional CO2 laser therapy in the treatment of hypertrophic scars and will develop an evidence-based protocol for the treatment of these scars in the pediatric population.

Eligible Conditions
  • Hypertrophic Scar

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Children between 1 and 17 years old who have scars that got thicker and raised after an injury or burn, but the scars are now closed and have been that way for at least 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cutometer measurements
Change in POSAS score
Change in SCAR-Q score
Secondary outcome measures
Change in appearance on Clinical Photographs of scars

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Laser treatment half of scarExperimental Treatment1 Intervention
The other half of the scar will receive standard scar treatment with topical products and pressure garments and, in addition, will receive ablative fractional CO2 laser treatment
Group II: Control half of scarActive Control1 Intervention
one half of the scar will receive standard scar treatment with topical products and pressure garments, but no ablative fractional CO2 laser

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,728 Total Patients Enrolled
Frankie Fraulin, MDPrincipal InvestigatorClinical Associate Professor

Media Library

Fractional CO2 Laser Treatment (Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04236167 — N/A
Hypertrophic Scar Research Study Groups: Control half of scar, Laser treatment half of scar
Hypertrophic Scar Clinical Trial 2023: Fractional CO2 Laser Treatment Highlights & Side Effects. Trial Name: NCT04236167 — N/A
Fractional CO2 Laser Treatment (Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04236167 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this scholarly endeavor enrolling seniors in its research?

"To be eligible for this trial, participants must hold a junior status of one year old to 17. On the other hand, patients below 18 can find 21 different clinical trials while those above 65 have 95 studies they could join."

Answered by AI

What is the uppermost capacity of enrollees for this medical experiment?

"Affirmative. According to the information on clinicaltrials.gov, this medical trial is presently seeking volunteers; it was first announced on November 1st 2020 and most recently modified 11/11/2022. For now, 44 patients are being accepted at one site for participation in the study."

Answered by AI

Who is eligible to take part in this research endeavor?

"This trial is seeking 44 individuals aged 1 to 17 that possess hypertrophic scars resulting from acute injury or burning. The necessary characteristics include the presence of a closed wound at least 3 months after closure and being within the specified age range."

Answered by AI

Is participation in the trial available to individuals at this time?

"According to the information provided on clinicaltrials.gov, this trial is currently open and inviting participants; it was uploaded onto the website on November 1st 2020 with its most recent update occurring a year later."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Alberta Children's Hospital
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Alberta Children's Hospital: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
~1 spots leftby Mar 2025